Janux Therapeutics Inc (JANX)

07:50 AM

Promising Developments and Strong Financial Position Support Buy Rating for Janux Therapeutics - TipRanks

07:50 AM

Mar 02, 2025

Positive Outlook for Janux Therapeutics Inc. Driven by Unique Therapeutic Potential and Strategic Advantages - TipRanks

Mar 02, 2025

Mar 01, 2025

Janux Therapeutics price target lowered to $41 from $62 at Scotiabank - Yahoo Finance

Mar 01, 2025

Feb 28, 2025

Janux Therapeutics Reports Strong Financial Position and Clinical Progress - TipRanks

Feb 28, 2025

Feb 28, 2025

Janux Therapeutics (NASDAQ:JANX) Announces Quarterly Earnings Results, Beats Estimates By $0.13 EPS - MarketBeat

Feb 28, 2025

Feb 28, 2025

Analyst Recommends ‘Buy’ for Janux Therapeutics Inc. Amid Share Price Decline and Promising Clinical Outlook - TipRanks

Feb 28, 2025

Feb 28, 2025

Promising Potential of Janux Therapeutics’ Lead Asset and Strategic Plans Justify Buy Rating - TipRanks

Feb 28, 2025

Feb 28, 2025

(JANX) Technical Data - Stock Traders Daily

Feb 28, 2025

Feb 28, 2025

Wedbush Adjusts Price Target on Janux Therapeutics to $76 From $75, Maintains Outperform Rating - Marketscreener.com

Feb 28, 2025

Feb 28, 2025

Cantor Fitzgerald maintains $200 target on Janux Therapeutics stock By Investing.com - Investing.com UK

Feb 28, 2025

Feb 27, 2025

Janux Therapeutics reports Q4 EPS (36c), consensus (45c) - TipRanks

Feb 27, 2025

Feb 27, 2025

Janux Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights - Business Wire

Feb 27, 2025

Feb 25, 2025

Janux Therapeutics stock hits 52-week low at $33.29 - Investing.com

Feb 25, 2025

Feb 25, 2025

Janux Therapeutics stock hits 52-week low at $33.29 By Investing.com - Investing.com Canada

Feb 25, 2025

Feb 25, 2025

Janux Therapeutics Insiders Sold US$6.9m Of Shares Suggesting Hesitancy - Simply Wall St

Feb 25, 2025

Feb 24, 2025

Janux Therapeutics Enters Oversold Territory (JANX) - Nasdaq

Feb 24, 2025

Feb 24, 2025

Janux Therapeutics, Inc. (JANX): Among the Oversold Biotech Stocks to Buy Now - Insider Monkey

Feb 24, 2025

Feb 24, 2025

10 Oversold Biotech Stocks to Buy Now - Insider Monkey

Feb 24, 2025

Feb 17, 2025

Trend Tracker for (JANX) - Stock Traders Daily

Feb 17, 2025

Feb 16, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Acquired by Lester Murray Antman dba SimplyRich - MarketBeat

Feb 16, 2025

Feb 13, 2025

abrdn plc Acquires New Holdings in Janux Therapeutics, Inc. (NASDAQ:JANX) - MarketBeat

Feb 13, 2025

Feb 12, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Receives $89.90 Average PT from Analysts - MarketBeat

Feb 12, 2025

Feb 12, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Receives $89.90 Average Price Target from Brokerages - Defense World

Feb 12, 2025

Feb 10, 2025

Quarterly Snapshot: Quick and Current Ratios for Janux Therapeutics Inc (JANX) - The Dwinnex

Feb 10, 2025

Feb 10, 2025

Mid-Cap Biopharma’s Biggest Winners And Losers Of 2024 - insights.citeline.com

Feb 10, 2025

Feb 09, 2025

Andrew Hollman Meyer Sells 3,334 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) Stock - MarketBeat

Feb 09, 2025

Feb 09, 2025

Janux Therapeutics (NASDAQ:JANX) Stock Price Up 6.9%Still a Buy? - MarketBeat

Feb 09, 2025

Feb 09, 2025

Janux Therapeutics (NASDAQ:JANX) Shares Down 4.2%Here's Why - MarketBeat

Feb 09, 2025

Feb 08, 2025

Janux Therapeutics Inc (NASDAQ: JANX) Gain Of 80.16% Compared To 52-Week Low; YTD Fall -26.47% – What Should You Do Now? – Marketing Sentinel - Marketing Sentinel

Feb 08, 2025

Feb 07, 2025

Janux Therapeutics Inc (JANX): Is It Worth A Small Bite At $40.68? - Stocks Register

Feb 07, 2025

Feb 07, 2025

Janux therapeutics' chief business officer sells shares worth $140,999 - MSN

Feb 07, 2025

Feb 07, 2025

The Volatility of Janux Therapeutics Inc’s (JANX) Stock: A -9.18% Ratio for the Week - The News Heater

Feb 07, 2025

Feb 06, 2025

Janux Therapeutics Inc (JANX) is looking forward to a strong quarter - SETE News

Feb 06, 2025

Feb 06, 2025

A Tale of Resilience: Janux Therapeutics Inc Amid Stock Market Turbulence - The InvestChronicle

Feb 06, 2025

Feb 05, 2025

Janux therapeutics’ chief business officer sells shares worth $140,999 By Investing.com - Investing.com Nigeria

Feb 05, 2025

Feb 05, 2025

Janux therapeutics' chief business officer sells shares worth $140,999 By Investing.com - Investing.com South Africa

Feb 05, 2025

Feb 05, 2025

Insider Sell Alert: Andrew Meyer Sells Shares of Janux Therapeutics Inc (JANX) - GuruFocus.com

Feb 05, 2025

Feb 05, 2025

Short Interest in Janux Therapeutics, Inc. (NASDAQ:JANX) Rises By 19.8% - MarketBeat

Feb 05, 2025

Feb 05, 2025

Janux Therapeutics Inc (JANX) stock on the rise: An overview - US Post News

Feb 05, 2025

Feb 04, 2025

Market Recap: Janux Therapeutics Inc (JANX)’s Negative Momentum, Closing at 42.07 - The Dwinnex

Feb 04, 2025

Feb 04, 2025

Monitoring Janux Therapeutics Inc (JANX) after recent insider movements - Knox Daily

Feb 04, 2025

Feb 01, 2025

Nisa Investment Advisors LLC Cuts Position in Janux Therapeutics, Inc. (NASDAQ:JANX) - MarketBeat

Feb 01, 2025